Total Funding
27
38
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
176055
Simmbion offers experimental solutions to the biologics problem based on engineering bacteria, fungi, or viruses.
Greg Merril: Executive DirectorPast Role: Adaptive Phage Therapeutics, Co-Founder & CEO- Derese Getnet: Founder and CEOPast Role: Walter Reed Army Institute of Research, Chief, Wound Infections Department
About the Company
Simmbion offers symbionts to produce therapeutic agents while avoiding dangerous infections or immune rejection. They supplant the need for complex manufacturing, repeated injections, long hours of infusions, temperature-sensitive storage, high cost of care, and associated compliance issues in a patient-centric, value-driven, and outcome-driven
healthcare model.
